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Yogavijayan Kandasamy1,2,3*, Roger Smith2, Eugenie R Lumbers2 and Donna Rudd3Abstract
Nephrin is a 180 KD trans-membrane protein expressed in glomerular podocytes. It was first identified in children
with congenital nephrotic syndrome of the Finnish type (NPHS1). Nephrin forms an integral part of podocytes,
which—together with endothelial cells and the basement—form the glomerular filtration barrier. Podocytopathies
result in the detection of nephrin in the urine. We reviewed the literature to determine if urine nephrin measurements
could become useful as a biomarker to detect early podocyte injury. Our search identified a total of 19 studies that have
been published to date. The most common clinical conditions for which urine nephrin analyses were carried out
included diabetic nephropathy, glomerulonephritis and pre-eclampsia. Nephrin measurement was carried out using
commercially available ELISA kits, the messenger ribonucleic acid real-time polymerase chain Reaction, or electrophoresis.
Nephrinuria showed positive correlation with proteinuria and severity of podocyte injury. In two studies, the level of
nephrinuria declined in conjunction with clinical improvement in the patient following immunosuppressive treatment.
Currently, there is no published data on the value of measuring urinary nephrin in pediatric patients.
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Congenital nephrotic syndrome of the Finnish type
(NPHS1) is an autosomal recessively inherited disorder
that is characterized in utero by fetal hydrops. It also
presents as nephrotic syndrome in neonates, a progres-
sive disease that leads to massive proteinuria and death
during the first two years [1]. This condition was first re-
ported in the Finnish population [2], but it has subse-
quently been recognized to occur elsewhere. Specifically,
by using linkage analysis in a cohort of 17 Finnish
families, the genetic locus for this disorder was mapped
to 19q12-q13 [3]. The NPHS1 (Nephrosis 1, congenital,
Finnish type) gene product Nephrin was subsequently
identified as a 180 KD transmembrane protein expressed
in glomerular podocytes [1]. Nephrin has also been de-
tected in the pancreas, brain, spinal cord and lymphoid
tissues [4], although its role in these tissues has not been
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Nephrin forms an integral part of podocytes, which—
together with endothelial cells and the basement—form
the glomerular filtration barrier [5]. The filtration
barrier consists of a basement membrane,a glomerular
endothelial cell monolayer, and a podocyte monolayer
on the urinary side [6]. Podocytes have four main
functions, which all depend on their unique and specialized
architecture. These functions are: the regulation of glomeru-
lar permeability selectivity, provision of structural support
for the glomerular capillary, remodeling of the glomerular
basement membrane (GBM), and endocytosis of filtered
proteins [7,8]. Podocytes can become injured in human and
experimental glomerular diseases and conditions that cause
podocyte injuries; these are collectively known as podo-
cytopathies [7]. Pollak et al. proposed the concept of
inherited podocytopathies [9]. It is now recognized that
the common feature in minimal change disease (MCD),
membranous glomerulopathy, crescentic glomeruloneph-
ritis, collapsing glomerulopathy, focal segmental glome-
rulosclerosis (FSGS), diabetic nephropathy, and lupus
nephritis is through podocyte damage and dysfunction [10].
Early events in the damaged podocyte are alterations of
the slit diaphragm, reorganization of the foot process
structure with the fusion of filtration slits, and apical dis-
placement. These preliminary changes may not be visibletral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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electron microscopy [10]. Early podocyte structural
change is characterized by detachment of podocytes from
the glomerular basement membrane. These changes can
lead to severe and progressive glomerular injuries, if the
condition persists. Hence, early recognition of any podo-
cyte injury is of clinical importance.
Methods
This review is intended to explore aspects associated
with the use of Nephrin as a marker in early podocyopa-
thies and it is not the intention of the authors to com-
ment on the molecular function of the protein nephrin.
We performed a review of the literature with PubMed,
US National Library of Medicine, EMBASE, and The
Cochrane Database of Systematic Reviews to determine
whether urinary nephrin could be used to detect early
glomerular injury. We used the following keywords:
nephrinuria, urinary nephrin, microalbuminuria, podocytes,
and glomerular injuries. The keywords were searched
alone or in combination with other keywords. We re-
viewed articles published between January 1990 and July
2014. Our search identified a total of 19 studies (6 in ani-
mals; 13 in human) that have been published to date. The
most common clinical condition in which urinary nephrin
analyses were carried out were diabetic nephropathy,
glomerulonepharitis, pre-eclampsia, and Systemic Lupus
Erythematosus (SLE).
Nephrin measurement
The most commonly used method for urinary nephrin
measurement was with the commercially available ELISA
kit ((Exocell, Philadelphia, PA; R&D Systems, Minneapolis,
MN, USA) [11-16]. In one study, the amount of podocy-
turia was also measured using urinary flow cytometry [17].
Other methods included messenger ribonucleic acid real-
time polymerase chain reaction (mRNA RT-PCR) [18-20],
electrophoresis [21-25]. In one study, the nature of the
analysis was not described [26]. Neprin measurement
using a commercially available ELISA kit has increasingly
becoming the method of choice for studies conducted
since 2012. However, no studies have compared the effi-
cacy of various methods for measuring urinary nephrin. In
a few studies, other podocyte protein measurements
(Podocalyxin [14] and Podocin [22]) were also carried out
concurrently with urinary nephrin but there were no at-
tempts to compare the sensitivity and specificity of these
urinary markers to each other.
Animal studies
Disease models investigated by animal studies can be di-
vided in 2 groups – nephrosis and diabetic nephropathy.
In both models, urine nephrin was detected early, prior
to significant albuminuria. Luimula et al. carried out astudy in which experimental glomerular disease was in-
duced in rats by using puromycin aminonucleoside
(PAN) [21]. PAN nephrosis results in effacement and fu-
sion of the podocyte foot processes, leading to the loss
of the ultrafiltration barrier, closely resembling the func-
tional and morphologic changes of minimal change dis-
ease. The investigators detected nephrin in urine in the
peak proteinuric samples and concluded that urinary
nephrin is an important marker of proteinuric diseases.
The investigators were however unable to determine
nephrin’s role in this study. In another study [22], the in-
vestigators used Heymann nephritis (a widely used ex-
perimental model to study idiopathic membranous
nephropathy) [27] to induce glomerular injury and to in-
vestigate the excretion of urinary nephrin as a result of
this injury. The investigators showed that nephrin was
excreted into urine during the initial stages of Heymann
nephritis, prior to any abnormal albuminuria. However,
the investigators from this study did not recognize this
nephrinuria as an early sign of glomerular injury and
concluded that nephrinuria may have contributed to the
development of proteinuria.
Aaltonen et al. investigated the role of nephrin in the
pathogenesis of diabetic nephropathy [23]. In this study,
the investigators used both the classic streptozotocin
(STZ) model of rat diabetes (selectively impairing the in-
sulin production in pancreatic beta cells, mimicking type
I diabetes) and spontaneously diabetic non-obese dia-
betic mice (a model for human insulin-dependent dia-
betes mellitus). The investigators found that nephrin was
detectable in urine of STZ-induced rats at 4 weeks,
which then peaked by 6 weeks. Urinary nephrin was de-
tected before the peak in albuminuria and the investiga-
tors concluded that nephrin was related to the early
changes of diabetic nephropathy. However, again the au-
thors concludedthat the appearance of nephrin in urine
contributed to the loss of glomerular function and failed
to recognise this as a marker of podocyte injury. In a
study by Alter et al., a group of 23 Wistar rats were un-
inephrectomized and randomly assigned to two groups
[28]. The study group received streptozotocin (STZ) to
induce diabetes mellitus, whereas the control group re-
ceived citrate buffer without STZ. Blood glucose levels,
blood pressure, kidney function, and weight were then
measured. After 18 weeks, blood and urine specimens
were collected, and then the animals were euthanized
and their organs harvested. The animals in the diabetic
group were found to have an elevated glucose level with
normal systolic blood pressure. The investigators found
that while there were no significant differences in renal
function and urinary albumin level between the two
groups, the urinary excretion of nephrin was signifi-
cantly higher in the diabetic group. Nephrin appeared
even before albuminuria, leading the study’s authors to
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possibility for early detection of nephropathy. In another
study, Chang et al. demonstrated similar findings in
Akita mice (a mouse model of type 1 diabetes mellitus
resulting from spontaneous point mutation in the Ins2
gene) [11]. In this study, the investigators found that
urinary nephrin excretion was significantly increased in
albuminuria in study of 16 and 20 week old mice and
that this correlated with the urinary albumin excretion
rate. Enhanced urinary nephrin excretion was shown to
be associated with kidney injury and was detected early
in the disease process. A similar finding was also re-
ported by O’Brien et al in another study [12]. Table 1
summarizes the animal studies that have been published
to date.
Human studies
Urinary nephrin measurements were carried out in 3
clinical conditions: diabetic nephropathy, nephrosis (in-
cluding Lupus nephritis) and preeclampsia.
Compared with the animal studies, human studies in-
volved larger sample size but on some occasions there
were no control groups [24].
Wang et al carried out a study to investigate the gene
expression of podocyte-associated molecules in the urin-
ary sediment of 21 patients with diabetic nephropathy
and 9 healthy controls [18]. The investigators found that
urinary nephrin levels (measured by mRNA expression)
correlated with proteinuria (r = 0.502, p = 0.020) but not
with eGFR. Nephrinuria was greater in diabetics with ne-
phropathy, and the investigators concluded that nephrin
measurement could play a role in clinical stratification of
the patients’ diabetic nephropathy. Do Nascimento et al.
used mRNA RT-PCR to measure urine nephrin in a
cohort of 15 controls and 67 diabetics [19]. The study sub-
jects were assigned to 3 different groups: normoalbumi-
nuria (NO) (<30 mg/g creatinine); microalbuminuria (MI)
(30–300 mg/g creatinine); and macroalbuminuria (MA)
(>300 mg/g creatinine). The investigators found that urine
nephrin was higher in diabetics than in non diabetics and
correlated with increasing albuminuria. Nephrinuria was
found in 53%, 71%, and 90% of NO, MI and MA diabetes
subjects, respectively (p = 0.023). The investigators con-
cluded that diabetic subjects had elevated urinary mRNA
levels of podocytes protein such as nephrin compared to
non- diabetic subjects, even the NO patients. In another
study, Patari et al. demonstrated the presence of nephrin
fragments using immunohistochemistry and western blot-
ting techniques in the urine of type 1 diabetics with or
without nephropathy [25]. The study consisted of five co-
horts of patients: 1) diabetic patients with normal albu-
minuria; 2) diabetics with microalbuminuria; 3) diabetics
who had developed microalbuminuria recently; 4) dia-
betics with macroalbuminuria; and 5) a control groupconsisting of healthy adults. Micro-albuminuria was de-
fined as a 24-h urinary albumin excretion rate (AER) of
30–300 mg in two of three consecutive 24-h urine collec-
tions; macroalbuminuria as an AER of 300 mg/24 h; and
normoalbuminuria as a persistent AER of 30 mg/24 h.
The investigators found that nephrinuria was present in
30% of normoalbuminuric, 17% of microalbuminuric, 28%
of macroalbuminuric, and 28% of new microalbuminuric
patients; however, none of the control subjects were
nephrinuric. The authors concluded that the glomerular
filtration barrier may already be compromised in one-
third of diabetic patients with nephrinuria.
In a recent study, Jim et al. investigated whether the
detection of nephrin in urine can be used as an early
biomarker of diabetic nephropathy [13]. Firstly, renal
histopathology in a group of 15 patients with type 2 dia-
betes was compared for the protein expression of nephrin
with a group of 12 control patients. This investigation
showed the statistically significant down-regulation of
podocin and nephrin in kidney biopsies for diabetic ne-
phropathy. Further, analysis of the study group, based on
the amount of albumin in urine, detected nephrinuria in
100% of diabetic patients with micro- and macroalbumi-
nuria and in 54% of patients with normoalbuminuria.
Nephrinuria correlated with albuminuria (rho = 0.89,
p = 0.001) and systolic blood pressure (rho = 0.32, p = 0.007).
It also correlated negatively with serum albumin (rho =
20.48, p = 0.0001) and eGFR (rho = 20.33, p = 0.005). The
investigators concluded that nephrinuria is a reliable bio-
marker of preclinical diabetic nephropathy.
In another study, Ng et al. investigated the association
between nephrinuria and various renal traits [24]. This
study, which recruited 381 patients with type 2 diabetes
mellitus, involved urinary nephrin analysis using electro-
phoresis and Western blot analysis. The electrophoretic
pattern revealed that nephrin was excreted in four dis-
tinct protein bands (25, 50, 60 and 75 kDa) with the
60 kDa molecule being the most common presentation
(40.7%). By using regression analysis, the investigators
showed that each nephrin fragment was associated with
a decrease in eGFR and that nephrinuria was strongly
associated with the urine albumin/creatinine ratio. This
finding was similar to that of another study involving 70
patients with diabetes mellitus [26].
Proletov et al. investigated daily urinary excretion of
nephrin as a possible marker for podocyte apoptosis
[29]. In this study, 71 patients with biopsy proven pri-
mary glomerulonephritis were recruited. The investiga-
tors found that urinary nephrin excretion (using ELISA)
correlated well with daily level of proteinuria (r = 0.67,
p < 0.05). Proteinuria and nephrinuria levels were lower in
patients undergoing treatment with cyclosporine. The
study showed that the more severe the degree of podocyte
injury (as evidenced by increased urinary nephrin), the
Table 1 Summary of the animal studies that have investigated the relationship between nephrinuria and glomerular injury
Authors Journal (Year)/PMID Study subjects
(sample size N)
Disease model Method of urine Results
Nephrin assay
Luimula et al. Pediatric Research
(2000)/11102543
Sprague–Dawley rats Puromycin aminoglycoside (PAN)
induced nephrosis (Minimal change
disease) Effacement and fusion of
Electrophoresis 1. Animals treated with puromycin developed albuminuria
starting at day 3, and reached maximum at day 6
Control = 6 Study = 12 2. Nephrin can be detected among urinary proteins
when the level of proteinuria exceeds 25 mg/mL
Nakatsue et al. Kidney Int.
(2005)/15882266
Wistar rats Idiopathic membranous
nephropathy (Heymann nephritis)
Electrophoresis
(Western blot)
1. Nephrin is excreted into urine in the early stages
of nephritis
Control = 5 Study = 16
Sprague–Dawley rats
Control = 3 Study = 3
Aaltonen et al. Lab. Invest
(2001)/11555666
Wistar rats Type 1 (Insulin-dependent)
diabetes mellitus and Diabetic
nephropathy
Electrophoresis 1. Free nephrin was found in the urine of STZ-induced
rats at 4 weeks and was at the maximum at 6 weeks
Control = 3 Study = 14
Non Obese diabetic mice 2. Nephrin is connected to the early changes of
diabetic nephropathy
Control = 3 Study = 9
Alter et al. Clin.Lab
(2012)/22997966
Wistar rats Streptozotocin (STZ) induced
Diabetes Mellitus and diabetic
nephropathy
ELISA (USCN Life Sci. Inc.
Burlington, NC, USA)
1. Nephrinuria detected prior to albuminuria and
renal impairment.
Control = 9 Study = 14 2. This biomarker offer an advantage to urinary albumin
with respect to early detection
Chang et al. Plos One
(2012)/22496773
Akita mice Type 1 diabetes mellitus and
diabetic nephropathy
ELISA (Exocell,
Philadelphia, PA)
1. Urinary nephrin excretion is associated with kidney
injury and is detectable early in the disease process.
Control = 8 Study = 8 2. Onset of hyperglycemia associated with nephrinuria
3. Nephrinuria rate has a positive correlation
with albuminuria
O’Brien et al. J of Diabetic Research
(2013)/Not available
Mice Obesity, Type 2 diabetes ELISA (Exocell,
Philadelphia, PA)
1. Nephrinuria correlates with albuminuria
Control = 12 Study = 12
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Table 2 Summary of the human studies
Authors Journal (Year)/PMID Study sample
size
Clinical condition Method of urine Results
Nephrin assay
Patari et al. Diabetes (2003)/14633858 Control = 29 Diabetic Nephropathy Electrophoresis
(Western blot)
1. Nephrinuria was present in 30% of normoalbuminuric, 17% of
microalbuminuric, 28% of macroalbuminuric,
Study = 120 2. None of the control subjects was nephrinuric.
Wang et al. Nephron Clin Pract.
(2007)/17596726
Control = 9 Diabetic nephropathy mRNA RT-PCR 1. Nephrinuria higher in patients with diabetic nephropathy compared
to control.
Study = 21 2. Nephrinuria correlated with proteinuria
Ng et al. Nephrol. Dial.Transplant
(2011)/21196468
Study = 381 Diabetic nephropathy Electrophoresis
(Western blot)
1. Each Nephrin fragment was associated with a decline in eGFR
2. Nephrinuria was strongly associated with the urine
albumin/creatinine ratio
3. Nephrinuria was significantly associated with lower eGFR even among
normoalbuminuric patients (ACR ≤30 mg/g)
Jim et al. PLoS ONE (2012)/22615747 Control = 12 Diabetic nephropathy ELISA (Exocell,
Philadelphia, PA)
1. Nephrinuria preceded microalbumniuria
Study = 15 2. Nephrinuria detected in all diabetic patients with micro and
macroalbuminuria
3. Nephrinuria also correlated significantly with albuminuria and
systolic blood pressure
4. Correlated negatively with serum albumin and eGFR
do Nascimento et al. BMC Nephrol.(2013)/24103534 Control = 15 Diabetic Nephropathy mRNA RT-PCR 1. Normoalbuniuric diabetics showed increased urinary nephrin compared
to control group
Study = 67 2. Nephrinuria correlated with diabetic nephropathy stages
Petrica et al. *Nephrology Dialy.Transpl
(2014)/NA
Control = 11 Diabetic nephropathy NA 1. Urine albumin creatinine ratio correlates with nephrinuria
Study = 70 2. Increased levels of urinary nephrin in normoalbuminuric and
microalbuniuruc patients
Wang et al. J Rheumatol (2007)/17985404 Control = 17 Systemic Lupus
Errythematosus (SLE)
mRNA RT-PCR 1. Nephrinuria higher in patients SLE nephritis
Study = 32 2. Nephrinuria correlated with proteinuria
3. Nephrinuria level correlated with severity of SLE disease activity
Tchebotareva et al. *Nephrology Dialy.Transpl
(2012)/NA
Study = 74 Glomerulonephritis ELISA 1. Nephrinuria correlated with proteinuria and severity of GN
2. Immunosuppressive therapy lowers nephrinuria levels
Proletov et al. *Nephrology Dialy.Transpl
(2014)/NA
Study = 71 Glomerulonephritis ELISA 1. Nephrinuria correlated with daily proteinuria
2. Nephrinuria and proteinuria lowest excretion in patients treated
with Cyclosporine.
Mehta et al. *AJKD (2012)/NA Control = 14 Preeclampsia ELISA (Exocell,
Philadelphia, PA)
1. Urine nephrin to creatinine ratio (UNCR) are predictive of preeclampsia
in second trimester of pregnancy
Study = 67
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Table 2 Summary of the human studies (Continued)
Wang et al. Am J Physiol Renal Physiol
(2012)/22301621
Control = 8 Preeclampsia ELISA (Exocell,
Philadelphia, PA)
1. Urinary Nephrin and podocalyxin concentrations were significantly
increased and highly correlated with each other in preeclampsia
Study = 26 2. Nephrin and podocalyxin were also correlated with urine protein
concentrations in preeclampsia
3. Nephrin undetectable in normal pregnancy
Son et al. Eur J Obstet Gynecol Reprod Biol.
(2013)/23116596
Control = 30 Preeclampsia ELISA (R&D Systems,
Minneapolis, MN, USA)
1. Nephrin was significantly higher in women with severe pre-eclampsia
Study = 43 2. Positive correlation between urinary nephrin and urine protein level
3. Urine nephrin concentrations correlated with diastolic blood pressure
and serum creatinine levels in the severe pre-eclamptic group
Jim et al. PLoS ONE (2014)/25010746 Control = 13 Preeclampsia ELISA (Exocell,
Philadelphia, PA)
1. Alb/Cr ratio had a high specificity (96%). All three biomarkers exhibited
poor positive predictive values (14–62%) but acceptable negative
predictive values (89–91%).Study = 78
mRNA RT-PCR: Messenger Ribonucleic acid Real-time Polymerase Chain Reaction; ACR = Albumin creatinine ratio; *- Conference abstract.
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evidenced by not only a decrease in urinary protein levels,
but also nephrin excretion. In another very similar study,
urine nephrin levels in a cohort of 74 adults with chronic
glomerulonephritis were measured, and the investigators
found that urine nephrin level exhibited a positive correl-
ation with the severity of the disease and proteinuria [17].
Urine nephrin measurement has also been used in studies
involving patients with lupus nephritis (LN) [20]. In this
study, a group of 49 (32 with active LN and 17 in remis-
sion) patients with LN were recruited. mRNA was used
determine urine nephrin levels, and the researchers found
that it was elevated in the active group and showed a posi-
tive correlation with proteinuria (r0.480, p < 0.01). The au-
thors concluded that urinary nephrin quantification could
play a role in the clinical classification of patients with LN.
More recently, urinary nephrin analyses have been
used to monitor pre-eclampsia and pregnancy-induced
hypertension. Wang et al. investigated the role of podo-
cyte protein shedding in pre-eclampsia, recruiting 34
pregnant women and dividing them into three groups
(normotensive, chronic hypertension, and pre-eclampsia)
[14]. Clinical information such as weight, blood pressure,
and gestation was recorded, and urine creatinine, albu-
min, and nephrin were analyzed. The investigators found
that nephrin was barely detectable in the urine speci-
mens of normal pregnant women and of those that had
chronic hypertension. In pre-eclamptic patients, how-
ever, urinary nephrin concentrations were significantly
increased. These results provide strong evidence that
podocyte protein shedding occurs in pre-eclampsia at
levels that correlate with proteinuria. In another study,
Son et al. compared urine excretion in a cohort of preg-
nant women with severe pre-eclampsia compared with
normotensive pregnant women [30]. The investigators
found urinary nephrin to be significantly higher in
women with severe pre-eclampsia and a positive correl-
ation between urinary nephrin and urine protein level.
Urine nephrin concentrations also correlated with dia-
stolic blood pressure and serum creatinine levels in the
severe pre-eclamptic group. The investigators concluded
that urinary nephrin excretion plays a critical role in the
pathogenesis of proteinuria during pre-eclampsia and
that it is a good indicator of renal damage. A similar con-
clusion was also made in another study by Mehta et al. of
67 high-risk obstetric patients [15]. In a more recent
study, Jim et al. found the sensitivity and specificity for
nephrinuria in detecting pre-eclampsia to be only 57%
and 58%, respectively [16]. Table 2 summarizes human
studies on nephrin measurement published to date.
Conclusion
Currently, urine micro-albuminuria is used as an early
indicator of glomerular injury. Both animal and humanstudies have demonstrated that nephrinuria occurs early
in glomerular injury, preceding albuminuria, and that
there is a positive correlation with severity of renal
diseases. Neprin detection in urine may also have role in
early detection of severe pre-eclampsia. Urine nephrin
analysis thus has the potential to become an important
biomarker of early glomerular injury. To date, no studies
on children or adolescents have been published, pointing
to a need for clinical studies using urinary nephrin to as-
sess, monitor, and prognosticate renal diseases in children.Competing interests
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